The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population

Mesnad Alyabsi, Mary Charlton, Jane Meza, Km Islam, Amr Soliman, Shinobu Watanabe-Galloway

Research output: Contribution to journalArticle

Abstract

Background: Rural residents are less likely to receive screening for colorectal cancer (CRC) than urban residents. However, the mechanisms underlying this disparity, especially among people aged 50-64 years old with private health insurance, are not well understood. We examined the impact of travel time on stage at CRC diagnosis. Methods: This retrospective cohort study used data from the Blue Cross and Blue Shield of Nebraska. Members of this private insurance company aged 50-64 years, diagnosed with CRC during the period 2012-2016, and continuously enrolled in the insurance plan for at least 6 months prior to CRC diagnosis, were selected for this study. Using Google Maps, we estimated patients' travel time from their home ZIP code to the ZIP code of their colonoscopy provider. Using logistic regression, we analyzed the association between stage at CRC diagnosis, travel time, use of preventive services (i.e., check-ups or counseling to prevent or detect illness at an early stage) and patient characteristics. Results: A total of 307 subjects met the inclusion criteria. People who had not used preventive services 6 months prior to CRC diagnosis had 2.80 (95% CI, 1.00-7.90) times the odds of metastatic CRC compared to those who had used these services. No statistically significant association was found between travel time and metastatic CRC diagnosis (P = 0.99; 95% CI, 0.98-1.01). Conclusions: The fact that 13% of the study population presented with metastatic CRC suggests some noncompliance with preventive services such as screening guidelines. To increase screening uptake and reduce metastatic cases, employers should offer incentives for their employees to make use of preventive services such as CRC screening.

Original languageEnglish (US)
Article number172
JournalBMC Health Services Research
Volume19
Issue number1
DOIs
StatePublished - Mar 18 2019
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Population
Blue Cross Blue Shield Insurance Plans
Insurance
Colonoscopy
Health Insurance
Early Detection of Cancer
Motivation
Counseling
Cohort Studies
Retrospective Studies
Logistic Models
Guidelines

Keywords

  • Access to care
  • Colorectal cancer
  • Geography
  • Health services research
  • Private insurance

ASJC Scopus subject areas

  • Health Policy

Cite this

The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population. / Alyabsi, Mesnad; Charlton, Mary; Meza, Jane; Islam, Km; Soliman, Amr; Watanabe-Galloway, Shinobu.

In: BMC Health Services Research, Vol. 19, No. 1, 172, 18.03.2019.

Research output: Contribution to journalArticle

Alyabsi, Mesnad ; Charlton, Mary ; Meza, Jane ; Islam, Km ; Soliman, Amr ; Watanabe-Galloway, Shinobu. / The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population. In: BMC Health Services Research. 2019 ; Vol. 19, No. 1.
@article{06ec9929ce5345529b6f6ed742ae1a89,
title = "The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population",
abstract = "Background: Rural residents are less likely to receive screening for colorectal cancer (CRC) than urban residents. However, the mechanisms underlying this disparity, especially among people aged 50-64 years old with private health insurance, are not well understood. We examined the impact of travel time on stage at CRC diagnosis. Methods: This retrospective cohort study used data from the Blue Cross and Blue Shield of Nebraska. Members of this private insurance company aged 50-64 years, diagnosed with CRC during the period 2012-2016, and continuously enrolled in the insurance plan for at least 6 months prior to CRC diagnosis, were selected for this study. Using Google Maps, we estimated patients' travel time from their home ZIP code to the ZIP code of their colonoscopy provider. Using logistic regression, we analyzed the association between stage at CRC diagnosis, travel time, use of preventive services (i.e., check-ups or counseling to prevent or detect illness at an early stage) and patient characteristics. Results: A total of 307 subjects met the inclusion criteria. People who had not used preventive services 6 months prior to CRC diagnosis had 2.80 (95{\%} CI, 1.00-7.90) times the odds of metastatic CRC compared to those who had used these services. No statistically significant association was found between travel time and metastatic CRC diagnosis (P = 0.99; 95{\%} CI, 0.98-1.01). Conclusions: The fact that 13{\%} of the study population presented with metastatic CRC suggests some noncompliance with preventive services such as screening guidelines. To increase screening uptake and reduce metastatic cases, employers should offer incentives for their employees to make use of preventive services such as CRC screening.",
keywords = "Access to care, Colorectal cancer, Geography, Health services research, Private insurance",
author = "Mesnad Alyabsi and Mary Charlton and Jane Meza and Km Islam and Amr Soliman and Shinobu Watanabe-Galloway",
year = "2019",
month = "3",
day = "18",
doi = "10.1186/s12913-019-4004-6",
language = "English (US)",
volume = "19",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The impact of travel time on colorectal cancer stage at diagnosis in a privately insured population

AU - Alyabsi, Mesnad

AU - Charlton, Mary

AU - Meza, Jane

AU - Islam, Km

AU - Soliman, Amr

AU - Watanabe-Galloway, Shinobu

PY - 2019/3/18

Y1 - 2019/3/18

N2 - Background: Rural residents are less likely to receive screening for colorectal cancer (CRC) than urban residents. However, the mechanisms underlying this disparity, especially among people aged 50-64 years old with private health insurance, are not well understood. We examined the impact of travel time on stage at CRC diagnosis. Methods: This retrospective cohort study used data from the Blue Cross and Blue Shield of Nebraska. Members of this private insurance company aged 50-64 years, diagnosed with CRC during the period 2012-2016, and continuously enrolled in the insurance plan for at least 6 months prior to CRC diagnosis, were selected for this study. Using Google Maps, we estimated patients' travel time from their home ZIP code to the ZIP code of their colonoscopy provider. Using logistic regression, we analyzed the association between stage at CRC diagnosis, travel time, use of preventive services (i.e., check-ups or counseling to prevent or detect illness at an early stage) and patient characteristics. Results: A total of 307 subjects met the inclusion criteria. People who had not used preventive services 6 months prior to CRC diagnosis had 2.80 (95% CI, 1.00-7.90) times the odds of metastatic CRC compared to those who had used these services. No statistically significant association was found between travel time and metastatic CRC diagnosis (P = 0.99; 95% CI, 0.98-1.01). Conclusions: The fact that 13% of the study population presented with metastatic CRC suggests some noncompliance with preventive services such as screening guidelines. To increase screening uptake and reduce metastatic cases, employers should offer incentives for their employees to make use of preventive services such as CRC screening.

AB - Background: Rural residents are less likely to receive screening for colorectal cancer (CRC) than urban residents. However, the mechanisms underlying this disparity, especially among people aged 50-64 years old with private health insurance, are not well understood. We examined the impact of travel time on stage at CRC diagnosis. Methods: This retrospective cohort study used data from the Blue Cross and Blue Shield of Nebraska. Members of this private insurance company aged 50-64 years, diagnosed with CRC during the period 2012-2016, and continuously enrolled in the insurance plan for at least 6 months prior to CRC diagnosis, were selected for this study. Using Google Maps, we estimated patients' travel time from their home ZIP code to the ZIP code of their colonoscopy provider. Using logistic regression, we analyzed the association between stage at CRC diagnosis, travel time, use of preventive services (i.e., check-ups or counseling to prevent or detect illness at an early stage) and patient characteristics. Results: A total of 307 subjects met the inclusion criteria. People who had not used preventive services 6 months prior to CRC diagnosis had 2.80 (95% CI, 1.00-7.90) times the odds of metastatic CRC compared to those who had used these services. No statistically significant association was found between travel time and metastatic CRC diagnosis (P = 0.99; 95% CI, 0.98-1.01). Conclusions: The fact that 13% of the study population presented with metastatic CRC suggests some noncompliance with preventive services such as screening guidelines. To increase screening uptake and reduce metastatic cases, employers should offer incentives for their employees to make use of preventive services such as CRC screening.

KW - Access to care

KW - Colorectal cancer

KW - Geography

KW - Health services research

KW - Private insurance

UR - http://www.scopus.com/inward/record.url?scp=85063126460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063126460&partnerID=8YFLogxK

U2 - 10.1186/s12913-019-4004-6

DO - 10.1186/s12913-019-4004-6

M3 - Article

C2 - 30885199

AN - SCOPUS:85063126460

VL - 19

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 172

ER -